Data protection Impressum

Newsroom

Biotech company CELLnTEC is playing a key role in the NEOLIVER project, a European-Swiss initiative developing the world’s first autologous bioprinted liver for clinical use. The project, co-funded by the EU and the Swiss government, aims to address the global organ donor shortage through innovative bioprinting technologies.

Bern-based CELLnTEC joins NEOLIVER project to develop bioprinted liver constructs

10 February 2025

Swiss coffee roaster La Semeuse marks its 125th anniversary with a major expansion in La Chaux-de-Fonds, investing CHF 10 million in a new roasting and storage facility.

La Semeuse celebrates 125 years and invests CHF 10 million in the canton of Neuchâtel

6 February 2025

The Foundation for Innovation and Technology has awarded Tech Grants to five promising projects from CHUV, EPFL, and HEIG-VD. The grants will support innovations in medical technology, robotics, and sustainable agriculture.

FIT awards Tech Grants to five cutting-edge projects from CHUV, EPFL and HEIG-VD

5 February 2025

Vaud-based AI company Largo.ai has raised CHF 7 million in a Series A round to accelerate its AI-driven solutions for film, TV, and advertising. Hollywood icon Sylvester Stallone joins as a strategic investor, marking a major step in the company’s expansion.

Largo.ai secures CHF 7 million to expand AI-driven film solutions

5 February 2025

Swiss start-ups raised CHF 2.4 billion in venture capital in 2024, marking an 8.5% decline from the previous year. The number of financing rounds also fell for the first time, reflecting a challenging investment climate. Despite these setbacks, biotech and cleantech sectors saw strong growth, and investor sentiment remains optimistic for 2025.

Swiss start-ups secure CHF 2.4 billion in 2024 amid shifting investment trends

4 February 2025

Inergio has successfully delivered its first fuel cell power units to customers in Europe and North America, marking a key milestone in its expansion. With increasing demand for its modular and fuel-flexible energy solutions, the company is scaling up production to meet growing off-grid power needs.

Cleantech Inergio delivers its first fuel cell power units to customers

4 February 2025

The Swiss Institute of Bioinformatics has inaugurated the Centre for Pathogen Bioinformatics in Bern, a state-of-the-art facility dedicated to strengthening genomic surveillance of infectious diseases.

The Centre for Pathogen Bioinformatics was inaugurated in Bern

4 February 2025

The Lausanne University Hospital (CHUV) has secured market authorization from Swissmedic to produce a fecal microbiota transplant (FMT) medication, making it the first accredited center in Switzerland to manufacture this treatment under strict pharmaceutical standards. This breakthrough provides an effective solution for patients suffering from recurrent Clostridioides difficile infections, a debilitating condition characterized by repeated digestive blowouts and severe discomfort.

CHUV becomes first Swiss hospital to produce gut-balancing medication

29 January 2025

The Human Lean Diagnostics (HLD) innovation cluster in Neuchâtel is preparing to welcome its first tenants in June 2025. Developed in collaboration with Microcity, the cluster is dedicated to accelerating medical diagnostics innovation by providing state-of-the-art infrastructure, fostering collaboration between industry and academia, and strengthening Switzerland’s position in health technology.

Neuchâtel’s Human Lean Diagnostics cluster is set to welcome its first tenants

29 January 2025

Voltiris has raised CHF 4.8 million in seed financing to advance its innovative solar energy solutions for greenhouses. Co-led by EquityPitcher Ventures and 3M Ventures, the funding supports the commercialization of its proprietary spectral filtering technology across Europe.

Voltiris secures CHF 4.8 million to transform solar energy use in greenhouses

28 January 2025

1 … 7 8 9 10 11 12 13 14 15 … 141